Response to the letter from Gozzetti et al. entitled: 'Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders'

Rule Simon

首页> 外文期刊>Leukemia and lymphoma >Response to the letter from Gozzetti et al. entitled: 'Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders'

【24h】

Response to the letter from Gozzetti et al. entitled: 'Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders'

机译：回应Gozzetti等人的来信。标题：“口服小剂量氟达拉滨和环磷酰胺联合利妥昔单抗作为老年慢性淋巴细胞增生性疾病的初始治疗”

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia and lymphoma》 |2015年第6期|共1页
作者
Rule Simon;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Response to the letter from Gozzetti et al. entitled: "Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders" [J] . Rule Simon Leukemia and lymphoma . 2015,第6期

机译：回应Gozzetti等人的来信。标题：“口服小剂量氟达拉滨和环磷酰胺联合利妥昔单抗作为老年慢性淋巴细胞增生性疾病的初始治疗”
2. Chemoimmunotherapy with oral low-dose fludarabine, cyclophosphamide and rituximab (old-FCR) as treatment for elderly patients with chronic lymphocytic leukaemia [J] . GozzettiA., CandiV., FabbriA., Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2014,第8期

机译：口服小剂量氟达拉滨，环磷酰胺和利妥昔单抗（old-FCR）的化学免疫疗法治疗老年慢性淋巴细胞性白血病
3. Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas. [J] . Alberto Fabbri, Emanuele Cencini, Luigi Rigacci, Leukemia and lymphoma . 2014,第4期

机译：利妥昔单抗加小剂量口服氟达拉滨和环磷酰胺作为老年顽固性非霍奇金淋巴瘤患者的一线治疗的有效性和安全性。
4. Clinical effectiveness and cost-effectiveness results from the randomised Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine cyclophosphamide and rituximab with fludarabine cyclophosphamide mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial. [O] . Dena R Howard, Talha Munir, Lucy McParland, -1

机译：在先前未经治疗的慢性淋巴细胞性白血病患者中进行的随机IIB期临床试验得出的临床有效性和成本效益比较了氟达拉滨环磷酰胺和利妥昔单抗与氟达拉滨环磷酰胺米托蒽醌和小剂量利妥昔单抗的比较：减毒剂量的利妥昔单抗联合慢性淋巴细胞化疗白血病（ARCTIC）试验。
5. Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia [O] . Kenneth A. Foon, Dhaval Mehta, Suzanne Lentzsch, 2012

机译：低剂量氟胺，环磷酰胺和高剂量戒指作为慢性淋巴细胞白血病患者的初始治疗的长期疗效

Response to the letter from Gozzetti et al. entitled: 'Oral low-dose fludarabine and cyclophosphamide with rituximab as initial treatment for elderly patients with chronic lymphoproliferative disorders'

著录项

相似文献

相关主题

期刊订阅